we could fall to .20 or lower technically. there is a lot

New Post Public Reply Private Reply Replies (1) Message Board
joey68 vietvetharry #894
1,075
we could fall to .20 or lower technically. there is a lot of momentum pushing all coins down right now, so yes its possible to see .70

the good thing is that this drop is not exclusive to XRP which indicates XRP is not at fault for this drop which means more than likely it will recover.

if i were looking to buy more or make my first purchase, id try to keep it simple by figuring out how much i REALLY need it to go down to make a noticeable difference in the size of my position.

for example, right now its @ .86. For $100, i could buy 116XRP

theres no point waiting for it to possibly go down to .85 because youd only benefit from one extra XRP.

But.. if its .86 right now, and youre feeling lucky that it may dip to .56 cents, thats an extra 62 XRP.. quite a large increase.

im babbling yet again. what im trying to say is, its impossible to get in a rock bottom prices. the second you try, it always skyrockets the next day. so.. get in at .86... or .70... does it make that much of a difference? not really.

but to penny pinch every last XRP possible.. id say theres probably a 45% chance XRP drops to .65 or lower in the next week or less. i honestly believe it will go lower, but the 45% number is from the chart and not personal opinion.
View My Board Here:
http://investorshangout.com/Joeys-Investment-Board-91611/


Invite Only

There is a VERY HIGH degree of RISK involved in trading and investing. Only invest what you can afford to lose.

Disclaimer:
As used herein, the terms "You" and "Your" shall mean you, individually, the reader, and each other party on whose behalf you may use the contained information at any time.
All references to "My", "I", and “The writer of the above post” shall refer to the creator of the username Joey68.

Do NOT invest unless you are prepared to sustain a total loss of the money you have invested plus any commission or other transaction charges.

There is a very high degree of risk involved in trading and investing. Past results are not indicative of future returns. I assume no responsibility for your trading and investment results. You should NOT rely on the information in the above post to make any decision or take any action.

ALL OF MY STATEMENTS, including but not limited to, POSTS, MESSAGES, PRIVATE MESSAGES, and RESPONSES are OPINION and NOT fact and are for entertainment purposes only. Do your own research and make your own decisions based on your own conclusions.
ALL OF MY STATEMENTS, including but not limited to, POSTS, MESSAGES, PRIVATE MESSAGES, and RESPONSES are NOT advice, and are NOT designed to substitute the expertise and judgment of a professional. It is your responsibility to seek investment advice during all stages of your investments. It is your responsibility to evaluate the accuracy, completeness and usefulness of the information in the above post.
I am NOT a professional.
I do NOT work for you.
My posts are NOT investment advice. I am not paid to post.
There is no correlation between the number of posts I write per day and your assumed success of a company.
It is NOT my responsibility to inform you of my own personal investment decisions.
It is NOT my responsibility to inform you when it is time for you to buy, hold, and/or sell a position.
I have no control over, and am not responsible for the actions of others who copy, store, edit, change, prepare any derivative work of or alter in any way any of the content provided in my posts.
Errors and Omissions expected. The writer of the above post accepts no liability or responsibility for any errors or omissions contained in the above post or contained within this Disclaimer.
The writer of the above post shall NOT accept any liability for the accuracy or completeness of the information contained in the above post, for any reliance placed by any person on the information contained in the above post, or for any damage or loss, however caused, in connection with the use or reliance on any information contained in the above post.
The above post may contain links to websites owned and operated by third parties. These links are provided for informational purposes only and are NOT endorsed by the writer of the above post. The writer of the above post has no control over the contents of any linked website and bears no responsibility for the accuracy, legality, or content of the external site or for that of subsequent links.
YOU ACCESS ALL LINKS ENTIRELY AT YOUR OWN RISK.
The writer of the above post makes no warranties or representations, express or implied about such linked websites, the third parties they are owned and operated by, or the information contained on these websites.
The writer of the above post accepts no liability for any damage or loss, however caused, in connection with the use of or reliance on any information, material, products, or services contained on or accessed through any such linked websites.

There is a VERY HIGH degree of RISK involved in trading and investing. Only invest what you can afford to lose.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 176

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading
Monster Energy Unleashes Gaming Frenzy at Cosm L.A. Event

Updated Category News Views 144

Where Energy Drinks and Digital Reality Collide Monster Energy sure knows how to throw a party, especially when it hinges on something as electrifying as Call of Duty: Modern Warfare 4. Imagine this: Cosm Los Angeles is decked out with a massive 87-foot LED dome, and every gamer, celeb, and influencer ready to dive right in. You can't make this stuff up. They've mashed...

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 295

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
Dr. Boonipat Inspires Future Women Surgeons at Texas Tech

Updated Category News Views 62

Sowing Surgical Seeds in Lubbock In Lubbock, Texas, something meaningful unfolded—an event the big market players would hardly blink at, but a significant step for the future of medicine. Led by Dr. Thanapoom "Mo" Boonipat, the founder of FacePlus Plastic Surgery Institute, a unique suturing workshop provided premed students at Texas Tech University hands-on experience...

Continue Reading
Love Business Group Helps SMEs Navigate Broadband Choices

Updated Category News Views 118

Understanding Broadband Needs for UK SMEs When you're knee-deep in running a small biz in the UK, sorting out your broadband needs can feel like sifting through a thousand-piece puzzle. Enter Love Business Group, getting a nod of recognition for being the SME knight in shining armor. Aimed at businesses of all sizes, they've been pegged by Expert Consumers for helping...

Continue Reading
Ping An's Bold Green Moves Ahead of APEC 2026

Updated Category News Views 175

Ping An's Pitch for Green: Talking the Talk and Walking the Walk? Well, here's something cooking in Shenzhen at the Ping An Finance Center—an international seminar championing green development initiatives. It's all buzz around Ping An Insurance (HKEX: 2318; SSE: 601318) flexing its green muscle, orchestrating conversations right before APEC 2026. Talk about timing....

Continue Reading
Tennessee's Bold Lung Cancer Trial Signals Innovation

Updated Category News Views 113

The Heartbeat of Innovation in Cancer Therapy Who would've thought Tennessee would be at the forefront of a global push against lung cancer? Sure, there's Nashville's music scene, but it's the researchers at Tennessee Oncology who are grooving to a different beat—one that might just set the rhythm for advanced cancer therapies worldwide. Yeah, it's a trial, but not just...

Continue Reading
Gildan Activewear Faces Legal Battle Over Alleged Fraud

Updated Category News Views 176

Investor Alert: Gildan's Legal Showdown Alright, here's a twist you didn't see coming—or maybe you did if you've been tracking the ticker tapes like a hawk. Gildan Activewear Inc. (NYSE:GIL) is stuck in the kind of hot water that can scald the bottom line. The Stakes: Racing Towards December 14 Marked on your calendar, December 14, is a date of some significance if...

Continue Reading
Ivonescimab Promises New Hope for Advanced BTC Patients

Updated Category News Views 280

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...

Continue Reading
Miranda Lambert Lights Up Red Kettle Campaign

Updated Category News Views 178

A Star-Studded Start to the Season of Giving Miranda Lambert is set to dazzle audiences yet again, and if there's one thing this country music titan knows, it's how to crank up the heartstrings while fanning the flames of generosity. She'll take to the stage at AT&T Stadium this Thanksgiving during the Dallas Cowboys game, bringing a powerful performance to light up the...

Continue Reading

Top 5 Most Recently Viewed Articles

CVS Unveils First Pharmacy-Focused Site in Houston

Updated Category News Views 19

A New Chapter in Pharmacy Care Alright, folks, CVS Health just threw its cowboy hat into the ring with a grand opening of its first pharmacy-focused spot down in south Houston. This ain't your typical retail maze—it's a compact little number designed to form tighter bonds between patient and pharmacist, and it's opening the doors to a shift in pharmacy care access. The...

Continue Reading
Rokmaster Resources Secures Key Exploration Permit for Future Growth

Updated Category News Views 181

New Exploration Permit Approved for Rokmaster Resources Rokmaster Resources Corp. (TSXV: RKR) is thrilled to announce the recent approval of a three-year exploration permit critical for their operations on the Fox-Coconut Property. This milestone marks an important step in the company's strategic plan, enabling them to embark on expansive exploration activities aimed at...

Continue Reading
Gleim Aviation's Innovative Solutions for Modern Pilot Training

Updated Category News Views 300

Gleim Aviation Showcases Innovative Training Solutions Gleim Aviation, known for its leadership in aviation education, is excited to unveil cutting-edge training technologies at EAA AirVenture Oshkosh, making waves in the aviation community. Visit Us at Hangar A, Booth 1104 From July 21 to July 27, Gleim Aviation invites flight training professionals, pilots, and aviation...

Continue Reading
Lennox Enhances HVAC Solutions with NSI Industries Acquisition

Updated Category News Views 174

Lennox Expands Its HVAC Offerings with New Acquisition Lennox, a prominent name in energy-efficient climate control solutions, has taken a significant step by acquiring the HVAC Division of NSI Industries. This notable acquisition includes the respected Duro Dyne and Supco brands, a move designed to enhance Lennox’s parts and supplies portfolio, offering better services...

Continue Reading
Quantum BioPharma Secures Investment Through Private Placement

Updated Category News Views 188

Quantum BioPharma Announces Private Placement Initiative Quantum BioPharma Ltd. (NASDAQ: QNTM) has embarked on a new phase of capital acquisition through a non-brokered private placement. This strategic move will involve issuing class A multiple voting shares (MVS) priced at $50 each, targeting an impressive total of $600 million in gross proceeds aimed at bolstering the...

Continue Reading